South Korean battery supplier SK On is looking at a different type of cooling method for electric vehicle battery packs. Last ...

Shares of 2seventy bio, Inc. TSVT gained 5.26% after the company announced a definitive merger agreement with Bristol Myers ...

BlackRock Health Sciences Term Trust is a top pick for high-yield dividends in healthcare. Click here to find out why BMEZ ...

NEW YORK – Bristol Myers Squibb and 2seventy Bio on Monday entered into a merger agreement in which BMS will acquire 2seventy for $286 million, ending the firms' cost-sharing agreement for the ...

The deal ends 2Seventy’s short run as an independent company, during which it restructured, sold off research and lost nearly ...

AFRICA is now an urban continent. In fact, it's urbanisation is being heralded a global megatrend, expected to rise to 60% by 2050, according to the Africa Union's (AU) Sustainable Urbanization for ...

More than a year into a strategic pivot to zero in on the multiple myeloma cell therapy Abecma, 2seventy bio is selling ...

Bristol Myers Squibb will acquire 2seventy bio for about $286 million in cash, sending the cancer cell therapy maker's shares ...

Abecma made $406 million in 2024, of which BMS paid $43 million to 2seventy bio as part of their profit-sharing agreement.

Smart buildings use advanced technologies to enhance energy efficiency, occupant comfort, and sustainability through ...

Abecma is being jointly developed and commercialized in the U.S. as part of a co-development, co-promotion, and profit share ...

More than a decade after Merck’s Keytruda and BMS’ Yervoy ushered in the immuno-oncology revolution, the space is at a ...